Background/aim: Multiple sclerosis (MS) is a common neurological disorder that can be a leading cause of nontraumatic disability in several countries. Recent reports have indicated a moderate to high risk of MS in European countries. In this study, we examined the prevalence of MS in a well-defined urban population of provincial center in Sivas Province in Turkey. Materials and methods:This study sampled all registered residents of urban areas of provincial center in Sivas Province in April 2017 and 2018 January. All the included patients met the McDonald 2010 criteria. Medical records were reviewed, including all available previously acquired magnetic resonance imaging data. All patients were subsequently subjected to neurologic examination to confirm the MS diagnosis. Results:We identified 21 possible MS patients, with MS diagnosis confirmed in 19. The prevalence of MS was 288 per 100,000 inhabitants. Conclusion:For future studies, these high ratio results can be used in regional and national comparisons to determine cofactors contributing to the high prevalence of MS in our region and can help health-decision makers to better plan healthcare policies to improve neurological services and awareness about multifaceted clinical presentations of MS.
Öz Amaç: Amacımız Sivas ili kırsalında bulunan bir ilçede, 6-18 yaş okula giden çocuk ve adölesanların obezite sıklığını belirlemek ve buna etki eden faktörleri tespit etmektir. Materyal ve Metot: Tanımlayıcı kesitsel tipteki çalışmamızın evrenini Sivas Akıncılar ilçesinde eğitim gören 485 öğrenci oluşturmakta idi. Çalışma 1-8 Haziran 2018 tarihinde, çalışmaya katılmayı kabul eden ve çalışmaya dahil edilme kriterlerini karşılayan 449 öğrenci üzerinde gerçekleştirildi. Onam formunu imzalayan velilerin çocuklarının boy, kilo, bel çevresi ve kalça çevresi araştırmacı tarafından ölçüldü ve 24 sorudan oluşan standardize anket formu velilere ulaştırıldı. Ölçümlerin değerlendirilmesinde Olcay Neyzi standartları (ulusal çalışma verileri ile oluşturulan) ve Centers for Disease Control and Prevention, CDC standartları kullanıldı.
The aim of this study was to determine the prevalence of autism spectrum disorder (ASD) in Sivas City Center and to investigate the ASD awareness of healthcare professionals working in Family Health Centers (FHC). Materials and Methods:The sample of the study consisted of 752 children aged between 18-72 months, 90 family physicians and 78 family health personnel (FHPs). The ASD Knowledge-Attitudes Scale and the ASD Awareness Questionnaire were administered to healthcare professionals. The Modified Checklist for Autism in Toddlers (M-CHAT) was applied to all of the children. Results: The mean scores of the ASD Knowledge-Attitude Scale and ASD Awareness Questionnaire of the family physicians were significantly higher than FHPs. The risk rate for ASD in screening was 6.25% (n=47), and the prevalence rate was 0.53%. Twenty of these children who were found to be at risk were evaluated by a child and adolescent psychiatrist. Of the 20 evaluated children, 7 were found to be normal, while 4 had a diagnosis of ASD, and 9 had other psychiatric diagnoses. Conclusion:This study showed that the prevalence rate of ASD in Sivas City Center is 0.53% and that the ASD awareness of family physicians is higher than that of FHPs. We believe that training programs to increase the awareness of healthcare professionals about ASD can contribute to the early detection of children with ASD. Amaç: Bu çalışmada Sivas İl Merkezi'nde otizm spektrum bozukluğunun (OSB) yaygınlığının saptanması ve Aile Sağlığı Merkezlerinde (ASM) görev yapan sağlık çalışanlarının OSB farkındalıklarının araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmanın örneklemi 18-72 ay arası 752 çocuk ve 90 aile hekimi ile 78 aile sağlığı elemanlarından (ASE) oluştu. Sağlık çalışanlarına OSB Bilgi ve Tutum Ölçeği ve OSB Farkındalık Anketi uygulandı. Çocukların tümüne Değiştirilmiş Erken Çocukluk Dönemi Otizm Tarama Ölçeği (M-CHAT) uygulandı. Bulgular: Aile hekimlerinin OSB Bilgi-Tutum Ölçeği ile OSB Farkındalık Anketi puan ortalamaları ASE'lerinkinden anlamlı olarak daha yüksekti. Taramada OSB için risk oranı %6.25 (n=47); yaygınlık oranı %0.53 olarak saptandı. Riskli saptanan bu çocukların 20'si çocuk ve ergen psikiyatrisi uzmanı tarafından değerlendirildi. Değerlendirilen 20 çocuğun 7'si normal saptanırken, 4'ü OSB tanısı, 9'u başka psikiyatrik tanılar aldı. Sonuç: Bu çalışma Sivas İl Merkezi'nde OSB yaygınlık oranının %0.53 olduğunu ve aile hekimlerinin OSB farkındalıklarının ASE'lerinkinden daha yüksek olduğunu gösterdi. Sağlık çalışanlarının OSB'ye ilişkin farkındalıklarının artmasına yönelik eğitim programlarının OSB'li çocukların erken saptanmasına katkı sağlayabileceği kanaatindeyiz.
Aim: The purpose of this study was to evaluate the role of WBC count, NLR, LMR, PLR, Systemic immune-inflammation index (SII) [(platelet count X neutrophil count) \ lymphocyte count] and platelet count (Plt)×NLR in the differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and malignant melanoma and to determine the effect of tumor type, prediction of lymph node metastasis at initial diagnosis and location on these inflammatory markers. Material and Method: Patients who underwent surgery for basal cell carcinoma, squamous cell carcinoma, or malignant melanoma were retrospectively screened. NLR, LMR, PLR, SII and Plt×NLR were calculated. Relationships between tumor type, prediction of lymph node metastasis at initial diagnosis, tumor localization and the inflammatory and hematological parameters of interest were investigated. Tumor location was classified as head and neck and others. Results: A total of 257 patients were included in the study. No statistically significant differences in WBC, NLR, PLR, LMR, SII or Plt×NLR were detected according to tumor location. The patients with squamous cell carcinoma had higher NLR, PRL, SII and Plt×NLR values than those with basal cell carcinoma. The risk of lymph node metastasis at the time of initial diagnosis was 10.3 times higher in patients with PLR levels of 180.7 and higher. The risk of lymph node metastasis detected at initial diagnosis was 8.9 times higher in patients with Plt×NLR of 747 and higher. The risk of lymph node metastasis detected at initial diagnosis was 7.1 times higher in patients with SII of 414 and higher. Conclusion: Inflammatory markers seem to be useful in the differential diagnosis of skin cancers and determined the risk of lymph node metastasis. However, it does not differ according to tumor localization.
Background: To determine the frequency of breastfeeding of mothers working in primary care, the differences between different employment groups, and the effective factors. Methods: This descriptive research study was conducted with a self-report online survey design. The snowball sampling method was used for the sample selection, and 151 family physicians and 126 family health professionals were included in the study during the research period (June 2019-December 2019). A 35-item survey was used to collect data. The response rate was 44.9% (49.5% family physicians/40.3% family health professionals). Results:The mean duration of exclusive breastfeeding was 3.9 ± 2.0 months, and the mean duration of total breastfeeding was 16.7 ± 8.5 months. There was no significant difference between the family physicians and family health professionals in terms of exclusive breastfeeding (P = .580) and total breastfeeding (P = .325) durations. The most common reasons for weaning were reduced milk supply (25.6%) and How to cite this article: Agadayi E, Nemmezi Karaca S, Ersen G, et al. Breastfeeding frequency of primary healthcare professionals and effective factors. Int J Clin Pract.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.